1. Home
  2. Live Updates
  3. Simplified disease activity

Live Breaking News & Updates on Simplified disease activity

Stay updated with breaking news from Simplified disease activity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Depression May Impact bDMARD Treatment Response and Discontinuation in Patients With Psoriatic Arthritis

Depression may impact PsA treatment response and lead to higher rates of bDMARD discontinuation, which may affect disease management and progression.

European-league-against-rheumatism , American-college-of-rheumatology , Hospital-anxiety , Depression-scale , American-college , Disease-activity-score , Clinical-disease-activity-index , Simplified-disease-activity , Ankylosing-spondylitis-disease-activity-score ,

Depression May Impact bDMARD Treatment Response and Discontinuation in Patients With Psoriatic Arthritis

Depression may impact psoriatic arthritis (PsA) treatment response and lead to higher rates of biologic disease-modifying antirheumatic drug (bDMARD) Depression may impact PsA treatment response and lead to higher rates of bDMARD discontinuation, which may affect disease management and progression.

American-college-of-rheumatology , European-league-against-rheumatism , Hospital-anxiety , Depression-scale , American-college , Disease-activity-score , Clinical-disease-activity-index , Simplified-disease-activity , Ankylosing-spondylitis-disease-activity-score ,

Depression May Impact bDMARD Treatment Response and Discontinuation in Patients With Psoriatic Arthritis

Depression may impact PsA treatment response and lead to higher rates of bDMARD discontinuation, according to results.

American-college-of-rheumatology , European-league-against-rheumatism , Hospital-anxiety , Depression-scale , American-college , Disease-activity-score , Clinical-disease-activity-index , Simplified-disease-activity , Ankylosing-spondylitis-disease-activity-score ,

Biologics Keep Early RA in Check for at Least 1 Year

New data confirm earlier shorter-term findings

John-gever , Clinical-disease-activity-index , Disease-activity-score , Simplified-disease-activity , Managing-editor , Rheum-dis ,

Possible Sex Differences Found in Early RA Drug Responses

In a rigorous analysis of sex differences in response to RA treatments, men had higher rates of remission than did women taking certolizumab pegol, abatacept, or conventional therapy.

Iceland , Vienna , Wien , Austria , Lisbon , Lisboa , Portugal , Netherlands , Stockholm , Sweden , London , City-of